Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment.

Kregel S, Wang C, Han X, Xiao L, Fernandez-Salas E, Bawa P, McCollum BL, Wilder-Romans K, Apel IJ, Cao X, Speers C, Wang S, Chinnaiyan AM.

Neoplasia. 2020 Jan 10;22(2):111-119. doi: 10.1016/j.neo.2019.12.003. [Epub ahead of print]

2.

Automatic reconstruction of the delivered dose of the day using MR-linac treatment log files and online MR imaging.

Menten MJ, Mohajer JK, Nilawar R, Bertholet J, Dunlop A, Pathmanathan AU, Moreau M, Marshall S, Wetscherek A, Nill S, Tree AC, Oelfke U.

Radiother Oncol. 2020 Jan 10;145:88-94. doi: 10.1016/j.radonc.2019.12.010. [Epub ahead of print]

PMID:
31931291
3.

Inflammation factors and element supplementation in cancer.

Jelińska M, Skrajnowska D, Wrzosek M, Domanska K, Bielecki W, Zawistowska M, Bobrowska Korczak B.

J Trace Elem Med Biol. 2020 Jan 8;59:126450. doi: 10.1016/j.jtemb.2019.126450. [Epub ahead of print]

PMID:
31931255
4.

Significance of desmoglein-2 on cell malignant behaviors via mediating MAPK signaling in cervical cancer.

Zhou BX, Li Y.

Kaohsiung J Med Sci. 2020 Jan 13. doi: 10.1002/kjm2.12182. [Epub ahead of print]

5.

Cancer risk among career male and female Florida firefighters: Evidence from the Florida Firefighter Cancer Registry (1981-2014).

Lee DJ, Koru-Sengul T, Hernandez MN, Caban-Martinez AJ, McClure LA, Mackinnon JA, Kobetz EN.

Am J Ind Med. 2020 Jan 12. doi: 10.1002/ajim.23086. [Epub ahead of print]

PMID:
31930542
6.

Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical nephroureterectomy.

Rosiello G, Palumbo C, Deuker M, Stolzenbach LF, Tian Z, Larcher A, Capitanio U, Montorsi F, Shariat SF, Kapoor A, Saad F, Briganti A, Karakiewicz PI.

J Surg Oncol. 2020 Jan 12. doi: 10.1002/jso.25840. [Epub ahead of print]

PMID:
31930511
7.

Angiotensin receptor autoantibodies as exposures that modify disease progression: Cross sectional, longitudinal and in vitro studies of prostate cancer.

Jain A, Shah H, Simonsick EM, Metter EJ, Mangold L, Humphreys E, Partin A, Fedarko NS.

J Transl Autoimmun. 2019 Dec;2. pii: 100008. doi: 10.1016/j.jtauto.2019.100008. Epub 2019 Aug 13.

8.

Rapid perceptual processing in two- and three-dimensional prostate images.

Treviño M, Turkbey B, Wood BJ, Pinto PA, Czarniecki M, Choyke PL, Horowitz TS.

J Med Imaging (Bellingham). 2020 Mar;7(2):022406. doi: 10.1117/1.JMI.7.2.022406. Epub 2020 Jan 3.

PMID:
31930156
9.

Eliminating microscopic lymph node metastasis by performing pelvic lymph node dissection during radical prostatectomy for prostate cancer.

Furubayashi N, Negishi T, Uozumi T, Shiraishi K, Taguchi K, Shimokawa M, Nakamura M.

Mol Clin Oncol. 2020 Feb;12(2):104-110. doi: 10.3892/mco.2019.1965. Epub 2019 Dec 13.

10.

Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells.

Zappavigna S, Abate M, Cossu AM, Lusa S, Campani V, Scotti L, Luce A, Yousif AM, Merlino F, Grieco P, De Rosa G, Caraglia M.

J Oncol. 2019 Dec 17;2019:9293560. doi: 10.1155/2019/9293560. eCollection 2019.

11.

Understanding Prostate Cancer in Gay, Bisexual, and Other Men Who Have Sex with Men and Transgender Women: A Review of the Literature.

Rosser BRS, Hunt SL, Capistrant BD, Kohli N, Konety BR, Mitteldorf D, Ross MW, Talley KM, West W.

Curr Sex Health Rep. 2019 Dec;11(4):430-441. doi: 10.1007/s11930-019-00234-7. Epub 2019 Nov 8.

PMID:
31929765
12.

HCRP-1 regulates cell migration, invasion and angiogenesis via Src/ FAK signaling in human prostate cancer.

Chen F, Wu J, Teng J, Li W, Zheng J, Bai J.

Int J Biol Sci. 2020 Jan 1;16(2):342-352. doi: 10.7150/ijbs.38112. eCollection 2020.

13.

Urethral realignment with maximal urethral length and bladder neck preservation in robot-assisted radical prostatectomy: Urinary continence recovery.

Heo JE, Lee JS, Goh HJ, Jang WS, Choi YD.

PLoS One. 2020 Jan 13;15(1):e0227744. doi: 10.1371/journal.pone.0227744. eCollection 2020.

14.

Loss of androgen signaling in mesenchymal sonic hedgehog responsive cells diminishes prostate development, growth, and regeneration.

Le V, He Y, Aldahl J, Hooker E, Yu EJ, Olson A, Kim WK, Lee DH, Wong M, Sheng R, Mi J, Geradts J, Cunha GR, Sun Z.

PLoS Genet. 2020 Jan 13;16(1):e1008588. doi: 10.1371/journal.pgen.1008588. eCollection 2020 Jan.

15.

Improvement of Constipation Symptoms in an Older Adult Patient by Defecation Care Based on Using a Handheld Ultrasound Device in Home Care Settings: A Case Report.

Matsumoto M, Yabunaka K, Yoshida M, Nakagami G, Miura Y, Okawa Y, Sugama J, Okada S, Ohta H, Sanada H.

J Wound Ostomy Continence Nurs. 2020 Jan/Feb;47(1):75-78. doi: 10.1097/WON.0000000000000610.

PMID:
31929449
16.

Prostate volume does not provide additional predictive value to prostate health index for prostate cancer or clinically significant prostate cancer: results from a multicenter study in China.

Huang D, Wu YS, Ye DW, Qi J, Liu F, Helfand BT, Zheng SL, Ding Q, Xu DF, Na R, Xu JF, Sun YH.

Asian J Androl. 2020 Jan 10. doi: 10.4103/aja.aja_136_19. [Epub ahead of print]

PMID:
31929198
17.

Genetic susceptibility of CYP1A1 gene and risk of pesticide exposure in prostate cancer.

Abhishek A, Ansari NG, Singh V, Sinha RJ, Mishra P, Mishra A.

Cancer Biomark. 2020 Jan 3. doi: 10.3233/CBM-190636. [Epub ahead of print] No abstract available.

PMID:
31929142
18.

Association between SOD2 V16A variant and urological cancer risk.

Zhang LF, Xu K, Tang BW, Zhang W, Yuan W, Yue C, Shi L, Mi YY, Zuo L, Zhu LJ.

Aging (Albany NY). 2020 Jan 12;12(1):825-843. doi: 10.18632/aging.102658. Epub 2020 Jan 12.

19.

Testosterone Therapy: What We Have Learned From Trials.

Corona G, Torres LO, Maggi M.

J Sex Med. 2020 Jan 9. pii: S1743-6095(19)31823-5. doi: 10.1016/j.jsxm.2019.11.270. [Epub ahead of print]

PMID:
31928918
20.

Definition of high-risk prostate cancer impacts oncological outcomes after radical prostatectomy.

Knipper S, Karakiewicz PI, Heinze A, Preisser F, Steuber T, Huland H, Graefen M, Tilki D.

Urol Oncol. 2020 Jan 9. pii: S1078-1439(19)30501-0. doi: 10.1016/j.urolonc.2019.12.014. [Epub ahead of print]

PMID:
31928867

Supplemental Content

Loading ...
Support Center